INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Dec 19, 2005 |
Director
Trans History: 742
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 303,909 | -- | 303,909 |
Dec 19, 2005 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,182 | -- | 17,182 |
Dec 19, 2005 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 182,818 | -- | 182,818 |
Nov 18, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Bona fide gift | 500 | -- | 4,871 |
Nov 08, 2005 |
Ten Percent Owner
Trans History: 1
|
Ten Percent Owner | Form 4 | Open market or private sale of non-derivative or derivative security | 7,527,050 | $11.06 | -- |
Sep 26, 2005 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 25,544 | -- | 415,424 |
Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 1,950 | $9.42 | 14,098 |
Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 2,881 | $9.43 | 11,217 |
Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 900 | $9.44 | 10,317 |
Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $9.45 | 10,217 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.